156 related articles for article (PubMed ID: 23945257)
1. Flotillin-2 is associated with breast cancer progression and poor survival outcomes.
Wang X; Yang Q; Guo L; Li XH; Zhao XH; Song LB; Lin HX
J Transl Med; 2013 Aug; 11():190. PubMed ID: 23945257
[TBL] [Abstract][Full Text] [Related]
2. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression.
Yan Y; Yang FQ; Zhang HM; Che J; Zheng JH
Tumour Biol; 2014 Oct; 35(10):10479-86. PubMed ID: 25053596
[TBL] [Abstract][Full Text] [Related]
4. High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma.
Liu Y; Lin L; Huang Z; Ji B; Mei S; Lin Y; Shen Z
Int J Clin Exp Pathol; 2015; 8(1):622-8. PubMed ID: 25755754
[TBL] [Abstract][Full Text] [Related]
5. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
[TBL] [Abstract][Full Text] [Related]
7. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β.
Zhao L; Lin L; Pan C; Shi M; Liao Y; Bin J; Liao W
Oncotarget; 2015; 6(12):9781-93. PubMed ID: 25909165
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival.
Li J; Zhang N; Song LB; Liao WT; Jiang LL; Gong LY; Wu J; Yuan J; Zhang HZ; Zeng MS; Li M
Clin Cancer Res; 2008 Jun; 14(11):3319-26. PubMed ID: 18519759
[TBL] [Abstract][Full Text] [Related]
9. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
[TBL] [Abstract][Full Text] [Related]
10. C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
Cheang TY; Zhou HY; Chen W; Zhang B; Liu L; Yang J; Wang S; Li H
J Transl Med; 2016 Feb; 14():54. PubMed ID: 26883017
[TBL] [Abstract][Full Text] [Related]
11. SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells.
Cao K; Xie D; Cao P; Zou Q; Lu C; Xiao S; Zhou J; Peng X
Oncol Res; 2014; 21(5):271-9. PubMed ID: 24854103
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Zeng Z; Lin H; Zhao X; Liu G; Wang X; Xu R; Chen K; Li J; Song L
Clin Cancer Res; 2012 Aug; 18(15):4059-69. PubMed ID: 22675169
[TBL] [Abstract][Full Text] [Related]
13. Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer.
Xu L; Peng S; Huang Q; Liu Y; Jiang H; Li X; Wang J
Oncol Rep; 2016 Oct; 36(4):1981-8. PubMed ID: 27573674
[TBL] [Abstract][Full Text] [Related]
14. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
15. Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis.
Sun F; Xiong Y; Zhou XH; Li Q; Xiao L; Long P; Li LJ; Cai MY; Wei YX; Ma YL; Yu YH
Tumour Biol; 2016 May; 37(5):6729-36. PubMed ID: 26662108
[TBL] [Abstract][Full Text] [Related]
16. FLOT2 overexpression is associated with the progression and prognosis of human colorectal cancer.
Li T; Cao C; Xiong Q; Liu D
Oncol Lett; 2019 Mar; 17(3):2802-2808. PubMed ID: 30854055
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
19. Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report.
You Y; Li H; Qin X; Ran Y; Wang F
Cell Oncol (Dordr); 2016 Feb; 39(1):89-95. PubMed ID: 26631111
[TBL] [Abstract][Full Text] [Related]
20. High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma.
Zhang SH; Wang CJ; Shi L; Li XH; Zhou J; Song LB; Liao WT
PLoS One; 2013; 8(6):e64709. PubMed ID: 23840303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
